Skip to content

Clinical Key Indicators and Bioinformatics Research of Patients with Chronic Heart Failure Comorbid with Cognitive Impairment

Clinical Key Indicators and Bioinformatics Research of Patients with Chronic Heart Failure Comorbid with Cognitive Impairment

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126444
Enrollment
Unknown
Registered
2026-06-09
Start date
2025-01-07
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure Comorbid with Cognitive Impairment

Interventions

Sponsors

Shijiazhuang Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age: 40-80 years; 2. Meets the diagnostic criteria for chronic heart failure, NYHA functional class II-IV; 3. Meets the neuropsychological scale (MMSE or MoCA) scoring criteria for cognitive impairment according to the "2018 Chinese Guidelines for the Diagnosis and Treatment of Dementia and Cognitive Disorders"; 4. Meets the diagnostic criteria for coronary heart disease: coronary angiography indicates stenosis >50%; 5. Subject has signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients whose scale assessment results are affected by severe hearing, speech disorders, or other physical diseases; 2. Those with a history of severe depression, anxiety, schizophrenia, or other mental illnesses; 3. Patients with dementia, Parkinson's syndrome, epilepsy, or other diseases; 4. Patients with severe liver, lung, or kidney dysfunction, severe endocrine diseases, hematological diseases, or severe infectious diseases; 5. Those who have had a new acute cerebrovascular event within the past month; 6. Those with a history of alcohol or drug abuse or dependence, or a history of taking special medications, such as sedatives; 7. Pregnant or breastfeeding women and those allergic to this drug; 8. Those who have used antibiotics or probiotics within the past three months.

Design outcomes

Primary

MeasureTime frame
Mini-Mental State Examination Score;Montreal Cognitive Assessment Score;Intestinal Microbiota;Intestinal Metabolomics;

Secondary

MeasureTime frame
Minnesota Living with Heart Failure Questionnaire;

Countries

China

Contacts

Public ContactYingying Chang

Shijiazhuang Traditional Chinese Medicine Hospital

Changyingying2012@163.com+86 185 3315 2733

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026